Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Prostatic Neoplasms 27Breast Neoplasms 23Neoplasm Metastasis 14Glioma 14Carcinoma, Non-Small-Cell Lung 14Lymphoma 12Lung Neoplasms 11Glioblastoma 11Neuroblastoma 10Lymphoma, Non-Hodgkin 9Carcinoma, Renal Cell 9Brain Neoplasms 9Medulloblastoma 8Ovarian Neoplasms 7Neoplasms 7Multiple Myeloma 7Ependymoma 7Carcinoma, Hepatocellular 7Wilms Tumor 6Thyroid Neoplasms 6Sarcoma 6Rectal Neoplasms 6Pancreatic Neoplasms 6Osteosarcoma 6Melanoma 6Fallopian Tube Neoplasms 6Central Nervous System Neoplasms 6Uterine Cervical Neoplasms 5Urinary Bladder Neoplasms 5Triple Negative Breast Neoplasms 5

Interventions

pazopanib 5Doxorubicin 3Bevacizumab 3carotuximab 2Sorafenib 2Radiotherapy, Conformal 2Paclitaxel 2Gemcitabine 2tremelimumab 1trebananib 1temsirolimus 1talimogene laherparepvec 1romidepsin 1regorafenib 1indolepropanol phosphate 1eribulin 1durvalumab 1cixutumumab 1Watchful Waiting 1Vascular Endothelial Growth Factor A 1TTI-621 1Sunitinib 1Sirolimus 1Razoxane 1Observation 1Magnetic Resonance Spectroscopy 1Ifosfamide 1HhAntag691 1Fluorodeoxyglucose F18 1Docetaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Hemangiosarcoma × Magnetic Resonance Spectroscopy × Clear all
NCT01462630 2022-08-19

Pazopanib Hydrochloride in Treating Patients With Advanced Angiosarcoma

Fox Chase Cancer Center

Phase 2 Completed
29 enrolled 10 charts
Sarcoma

Hemangiosarcoma, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡